## APPN: Appian Corporation - XLK: Technology

### Executive Summary

VALUE thesis: PEG 0.12 indicates fundamental undervaluation. Analyst consensus $41 (+21% upside). Consistent execution (4/4 quarters beat estimates). Caution: momentum weakening (-2.3% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($31.04)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 3 ($0.00M) |
| Sells | 2 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 44.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 13.9% (+13.0%)
- Blackrock Inc.: 8.0% (+6.7%)
- Lead Edge Capital Ma: 4.2% (+11.5%)
- Abdiel Capital Advis: 3.1% (-82.8%)
- Arrowstreet Capital,: 3.0% (+86.9%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-2.3% 5d) with bearish MACD, trend may be turning.
2. Near-term weakness: 10.2% below SMA50 despite long-term uptrend.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.12 indicates undervaluation relative to growth. Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $2.5B |
| Beta | 0.83 |
| 52W Range | $24.00 - $46.06 |
| Short Interest | 7.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.12 |
| Forward P/E | 43.9 |
| Current P/E | 62.3 |
| YoY Growth | 42.0% |
| EPS Direction | RISING |

### Technicals

MRS_20 deteriorating from -7.6% to -9.9% (-2.3% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 13.9pp (needs >4.0% for momentum thesis). AM_20 at -9.8% indicates price below own 20MA trend. Underperforming sector by 9.5pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.06x) but short-term weakness (below SMA20). OFD pattern: -SUN (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -9.88% (CS: 1) | Weak |
| RSI_14 | 32.8 | Neutral |
| MACD Histogram | -0.45 | Bearish |
| vs SMA20 | 0.902x | Below |
| vs SMA50 | 0.898x | Below |
| vs SMA200 | 1.059x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $33.76
- **Stop Loss:** $31.04 (8.1% risk)
- **Target:** $39.20 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 422
- **Position Value:** $14,246.72
- **Portfolio %:** 14.25%
- **Risk Dollars:** $1,150.00
- **Risk Per Trade:** 1.15%
- **Modifiers:** L1 115% | L2 100% | Combined 1.15x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite. VIX remains calm at 14.9 (8th percentile) with positive yield curve (+65bps) and healthy breadth (59.2%), though elevated put/call ratio (1.27) suggests institutional hedging despite surface calm. Focus on quality with awareness of hedging activity divergence.*

### Earnings

**Next:** 2026-02-18 (Est: $0.08)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.05 | $0.32 | +490.0% |
| 2025Q2 | $-0.13 | $0.00 | +103.0% |
| 2025Q1 | $0.03 | $0.13 | +315.7% |
| 2024Q4 | $-0.01 | $0.00 | +100.0% |

---
*RULE-based L3 | 2026-01-07 09:36 | MRS_20*